
Management Change30 Sept 2026, 08:01 pm
Aarti Drugs: Chairman, MD & CEO Prakash Patil Resigns; Adhish Patil Becomes MD
AI Summary
Aarti Drugs Ltd has announced significant changes in its Directorate and Key Managerial Personnel. Shri Prakash M. Patil has ceased to hold the positions of Chairman, Managing Director, and Chief Executive Officer, effective September 30, 2026, due to his decision to take early retirement. Concurrently, Shri Adhish P. Patil has been promoted to the position of Managing Director, effective October 1, 2026. As a result of this promotion, Shri Adhish P. Patil has relinquished his role as Chief Financial Officer, also effective September 30, 2026. The company intends to appoint a new CFO in due course.
Key Highlights
- Prakash M. Patil resigns as Chairman, MD, and CEO for early retirement.
- Adhish P. Patil promoted to Managing Director from CFO.
- Cessation and promotion effective end of September/start of October 2026.
- Company to appoint a new Chief Financial Officer shortly.
Price Impact
More from AARTIDRUGS